All HIV articles
-
NewsNew dosing data expands HIV treatment options for newborns
Newborns with HIV can now be treated with dolutegravir from the first days of life. An international clinical study identified a safe dosing regimen that produced drug levels comparable to those seen in older children and adults, helping support the FDA’s expanded approval.
-
NewsResearchers engineer more sensitive CRISPR tool for virus detection
Researchers have engineered a more sensitive version of the RNA-targeting CRISPR enzyme Cas13a, improving its detection performance by 100-fold without sacrificing stability. The tool could support faster and more adaptable tests for HIV and a wide range of other RNA viruses.
-
NewsResearchers identify the immune cells that keep a deadly fungus in check
A new study finds that control of Cryptococcus neoformans depends not on a single immune cell type, but on several working together — a discovery that could reshape how doctors think about preventing life-threatening fungal infections.
-
NewsWhy immune responses to vaccines vary from person to person
A new study finds that past immune encounters may predict future vaccine response.
-
NewsA new HIV vaccine study reveals new hope—and new challenges—for aging patients
A new clinical trial demonstrates that novel vaccines can significantly boost T cells targeting and could contribute to curative approaches against HIV.
-
NewsSurvey highlights persistent uncertainty on STI vaccines
A nationally representative survey of empaneled adults finds that while most Americans understand how STIs spread, there are significant gaps in public knowledge about which infections can be prevented through vaccination.
-
NewsNanodisc platform improves vaccine design for Ebola, HIV and more
Scientists have created a platform that allows viral surface proteins to be studied in a form that more closely resembles how they appear naturally, utilizing nanodisc technology where these proteins are embedded into particles made of lipid molecules, preserving them in a membrane-like structure.
-
NewsInternational experts connect infections and aging through cellular senescence
Researchers propose the concept of infection-driven senescence (IDS) to describe the phenomenon in which microbial agents, beyond viruses, can trigger cellular senescence in host cells.
-
NewsMaldives is first country to achieve ‘triple elimination’ of mother-to-child transmission of HIV, syphilis and hepatitis B
The World Health Organization has validated the Maldives for eliminating mother-to-child transmission of hepatitis B, while maintaining its earlier validation for EMTCT of HIV and syphilis. This makes the Maldives the first country in the world to achieve ‘triple elimination’.
-
NewsU.S. Public Health Service releases new guidelines on occupational HIV exposure and postexposure prophylaxis
The CDC, on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to Human Immunodeficiency Virus (HIV) and Recommendations for Postexposure Prophylaxis (PEP).
-
NewsScientists discover viral trapdoor blocking HIV and herpes
A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure in these viruses and then trap them ...
-
NewsInstitut Pasteur and UCSF QBI team up to create centre of excellence
The Institut Pasteur and UC San Francisco Quantitative Biosciences Institute (UCSF QBI) have announced a new partnership for the joint establishment of the Institut Pasteur-UCSF QBI Center of Excellence in Emerging Infectious Diseases, with planned operations in San Francisco and Paris.